Submitted via IRC for chromas
First FDA approved cannabis-based drug now available by prescription
The first cannabis-derived medication approved by the Food and Drug Administration is now available by prescription in every state, according to its manufacturer.
Epidiolex, manufactured by GW Pharmaceuticals, is intended to treat seizures associated with two rare and severe forms of epilepsy that begin in childhood. The drug is made of cannabidiol (CBD), a component of marijuana that doesn't give users a high.
"Because these patients have historically not responded well to available seizure medications, there has been a dire need for new therapies that aim to reduce the frequency and impact of seizures," Justin Gover, CEO of GW Pharmaceuticals, said in a statement.
From the DEA website:
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote
(Score: 2) by sjames on Friday November 02 2018, @01:53AM (1 child)
How much more expensive is this new drug compared to the cost of perfectly good pot on the street corner vs. the cost of a CBD rich strain from a dispensary in states where that exists?
(Score: 1, Funny) by Anonymous Coward on Friday November 02 2018, @02:09AM
This drug would be indicated in patients who also sufferer from cannabis derangement syndrome. :-)
(i.e. regular CBD oil would trigger CDS symptoms, but sufficient marketing and picking a chemical nomenclature that doesn't include "canna" should have a placebo effect, preventing a CDS episode.)